Extensive chemical library Aurora maintains a vast in-stock library of 18.1 million compounds for R&D, enabling rapid sourcing for drug discovery projects and custom synthesis engagements.

Drug discovery focus With capabilities in small molecules, natural products, peptides, and fragment-based libraries, Aurora can position as a one-stop partner for lead generation, hit to lead optimization, and structure-guided design.

Advanced modeling In-house molecular modeling and first-principles quantum mechanical analysis support rational design efforts, offering value-add services for target-driven project workflows and computational chemistry collaborations.

Global research enablement Laboratories equipped for synthesis and comprehensive analytical capabilities (GC, HPLC, IR, NMR, MS, elemental, crystallography) facilitate end-to-end support from synthesis to characterization across international labs.

Growth potential Private, small-team operation with substantial IP-driven capabilities and a scalable software platform presents opportunities to upsell discovery services, custom synthesis projects, and licensing of computational tools to larger pharma and biotech clients.